Dr. Red­dy's and Stan­ford spin­out Kain­o­myx part­ner up on an­ti-malar­i­al pro­gram

Dr. Red­dy’s Lab­o­ra­to­ries, its CRD­MO arm Au­ri­gene and Stan­ford spin­out Kain­o­myx are team­ing up to de­vel­op an an­ti-malar­i­al drug with a new mech­a­nism of ac­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER